Javier Orozco, MD, MSc (@javierorozcomd) 's Twitter Profile
Javier Orozco, MD, MSc

@javierorozcomd

Assistant Professor. Sr Clinical Research Scientist. Saint John's Cancer Institute at Providence Saint John’s Health Center

ID: 2385040977

calendar_today05-03-2014 10:34:02

36 Tweet

65 Followers

110 Following

Society of Surgical Oncology (@socsurgonc) 's Twitter Profile Photo

SSO is proud to partner with the Korean Breast Cancer Society on the upcoming webinar, "Selective Omission of Sentinel Lymph Node Biopsy in cN0 Patients". Register to join the discussion on December 2 at ow.ly/toRL50LE6Xz .

SSO is proud to partner with the Korean Breast Cancer Society on the upcoming webinar, "Selective Omission of Sentinel Lymph Node Biopsy in cN0 Patients". Register to join the discussion on December 2 at ow.ly/toRL50LE6Xz .
ASBrS (@asbrs) 's Twitter Profile Photo

Re-excising positive margins after a cosmetic breast reduction can prove challenging. Javier Orozco, MD, MSc discusses their approach to remove additional tissue and maintain excellent cosmesis. #ASBrS23 Janie Grumley, MD

Re-excising positive margins after a cosmetic breast reduction can prove challenging. <a href="/JavierOrozcoMD/">Javier Orozco, MD, MSc</a> discusses their approach to remove additional tissue and maintain excellent cosmesis. #ASBrS23 <a href="/janiedg/">Janie Grumley, MD</a>
IdISBa Cancer Epigenetics Lab (@idisbaepigen) 's Twitter Profile Photo

🚨#PreprintAlert🚨. Is chromatin folding involved in cancer cell invasion? This study discovered that the expression of a set of matrix metalloproteinases (MMP) is controlled by a single insulator element. (1/8)🧵 researchsquare.com/article/rs-290…

Katherine Jackson (@kmjacksonmd) 's Twitter Profile Photo

For large or multiple breast lesions, oncoplastic BCS is associated with decreased cost, fewer surgeries and complications, shorter time to completion of surgical therapy and similarly excellent cosmesis compared to mastectomies. Janelle Millen Janie Grumley, MD Donald L. Morton CGSO Fellowship Program #asbrs24

For large or multiple breast lesions, oncoplastic BCS is associated with decreased cost, fewer surgeries and complications, shorter time to completion of surgical therapy and similarly excellent cosmesis compared to mastectomies. <a href="/MillenJanelle/">Janelle Millen</a> <a href="/janiedg/">Janie Grumley, MD</a> <a href="/DLM_SurgOnc/">Donald L. Morton CGSO Fellowship Program</a> #asbrs24
Janie Grumley, MD (@janiedg) 's Twitter Profile Photo

Excellent presentation from our current fellow Dr. Nicketti Handy on oncoplastic treatment of male breast cancer with immediate nipple areola reconstruction! So proud! 👏👏👏#ASBRS24 @mpbcbreasties SJCI Breast Surgical Oncology Fellowship

Excellent presentation from our current fellow Dr. Nicketti Handy on oncoplastic treatment of male breast cancer with immediate nipple areola reconstruction! So proud! 👏👏👏#ASBRS24 @mpbcbreasties <a href="/sjcibreast/">SJCI Breast Surgical Oncology Fellowship</a>
Javier Orozco, MD, MSc (@javierorozcomd) 's Twitter Profile Photo

Very happy to share our study on the effects of #IORT on ER-positive/HER2-negative #breastcancer at Front Immunol ✅ Potential for IORT to transform "cold" into “hot” tumors. 10.3389/fimmu.2024.1373497 #Immunotherapy ProvidenceCalifornia @janiegrumley

Very happy to share our study on the effects of #IORT on ER-positive/HER2-negative #breastcancer at Front Immunol

✅ Potential for IORT to transform "cold" into “hot” tumors.

10.3389/fimmu.2024.1373497

#Immunotherapy
<a href="/ProvCalifornia/">ProvidenceCalifornia</a>
@janiegrumley
Annals of Surgical Oncology (@annsurgoncol) 's Twitter Profile Photo

#AudioVisualAbstract : Simultaneous Symmetry Procedure in Patients Undergoing #Oncoplastic #BreastConservingSurgery: An Evaluation of Patient Desire and Revision Rates Javier Orozco, MD, MSc Janie Grumley, MD rdcu.be/dGxBX Sarah L. Blair

IdISBa Cancer Epigenetics Lab (@idisbaepigen) 's Twitter Profile Photo

🔬 Descubriendo el poder oculto del "ADN basura" para combatir tumores agresivos 🧬 Hemos revelado cómo la "materia oscura" del ADN, antes llamada "ADN basura", podría ser clave para mejorar el tratamiento y diagnóstico de tumores agresivos. 🌟

🔬 Descubriendo el poder oculto del "ADN basura" para combatir tumores agresivos 🧬

Hemos revelado cómo la "materia oscura" del ADN, antes llamada "ADN basura", podría ser clave para mejorar el tratamiento y diagnóstico de tumores agresivos. 🌟